Feyzi Birol Sarica

Dr. Feyzi Birol Sarica


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Asian Journal of Neurosurgery
Verified
Journal Article
Open access
PDF file
TKTufan Kadir
Tufan Kadir
FSFeyzi Birol Sarica
Feyzi Birol Sarica
KOKardes Ozgur
Kardes Ozgur
MCMelih Cekinmez
Melih Cekinmez
ANAltinors Mehmet Nur
Altinors Mehmet Nur
Myelopathy is a rare but serious complication of radiation therapy (RT). Radiation myelopathy is white matter damage to the spinal cord developed after a certain period of application of ionizing radiation. Factors such as radiation dose and time between applications affect the occurrence as well as the severity of myelopathy. In those patients, positron emission tomography/computed tomography examination has a very important role both in the diagnosis and in the differential diagnosis of lesions. In this case report, the case of progressive paraparesis, developed in a 52-year-old female patient operated with pulmonary mucinous cystadenocarcinoma diagnosis and who received chemotherapy and RT following surgery, has been reported.

1 January 2012 in Asian Journal of Neurosurgery
Verified
Journal Article
Open access
PDF file
FSFeyzi Birol Sarica
Feyzi Birol Sarica
MCMelih Cekinmez
Melih Cekinmez
OSOrhan Sen
Orhan Sen
HOHuseyin C Onal
Huseyin C Onal
HMHuseyin Mertsoylu
Huseyin Mertsoylu
ETErkan Topkan
Erkan Topkan
Background: Anaplastic astrocytoma (AA; WHO grade-III) patients determination of prognostic factors helps generating multimodal therapy protocols. For this purpose, in the Baskent University, Adana Medical Research Center, specific characteristics of AA patients who have surgery were retrospectively investigated and factors which affect prognosis has been determined. Patients and Methods: Between January 2005 and 2009, 20 patients who have AA have been evaluated retrospectively. Totally, 20 patients had 31 operations. Sixteen patients had only adjuvant radiation therapy (RT). In the postoperative period, 8 patients received adjuvant RT. Nine of 10 patients with tumor recurrence received concomitant therapy with temozolomide (ConcT with TMZ) protocol. No adjuvant therapy protocol could be applied in three patients with poor general condition in the postoperative period. Results: Median survival for patients died was 16±17 months; one year survival was 75% and five year survival 25%. After univariate analysis, preoperative Karnofsky performance score (KPS) was ≥80 ( P=0.005577*), postoperative KPS was ≥80 ( P=0.003825*), type of tumor resection ( P=0.001751*), multiple operations ( P=0.006233*), and ConcT with TMZ protocol ( P=0,005766*) were all positive prognostic factors which extend the survival. Conclusions: The results of the multivariate analysis did not put forward an independent prognostic factor acting on the survival period ( P>0.05).


1 January 2008
Verified
Journal Article
Closed access
FSFeyzi Birol Sarica
Feyzi Birol Sarica
MCMelih Cekinmez
Melih Cekinmez
KTKadir Tufan
Kadir Tufan
BEBülent Erdoğan
Bülent Erdoğan
OSOrhan Sen
Orhan Sen
MAMehmet Nur Altinörs
Mehmet Nur Altinörs

1 July 2009
Verified
Journal Article
Closed access
FSFeyzi Birol Sarica
Feyzi Birol Sarica
KTKadir Tufan
Kadir Tufan
MCMelih Cekinmez
Melih Cekinmez
BEBülent Erdoğan
Bülent Erdoğan
MAMehmet Nur Altinörs
Mehmet Nur Altinörs

1 January 2008
Verified
Journal Article
Closed access
FSFeyzi Birol Sarica
Feyzi Birol Sarica
BEBülent Erdoğan
Bülent Erdoğan
KTKadir Tufan
Kadir Tufan
MCMelih Cekinmez
Melih Cekinmez
OKOsman Kizilkiliç
Osman Kizilkiliç
MAMehmet Nur Altinörs
Mehmet Nur Altinörs